From: Neoadjuvant chemotherapy followed by hyperthermic intraperitoneal chemotherapy for patients with colorectal peritoneal metastasis: a retrospective study of its safety and efficacy
Preoperative chemotherapy regimens
N (%)
XELOX
5 (25.0)
XELOX+bevacizumab
2 (10.0)
FOLFOX
FOLFIRI
3 (15.0)
FOLFOX+bevacizumab
FOLFIRI+bevacizumab
5-FU+leucovorin
1 (5.0)